. 2019 Oct 17;9:14907. doi: 10.1038/s41598-019-51445-w

Table 2.

Tumor-to-organ ratios of in BALB/C nu/nu mice bearing SK-RC-52 OV xenografts.

	[¹¹¹In]In-DOTA-HE₃-ZCAIX:2	[^99mTc]Tc(CO)₃-HE₃-ZCAIX:2	[¹¹¹In]In-DTPA-G250(Fab’)₂	[¹¹¹In]In-DTPA-G250(Fab’)₂
	4 h	4 h	4 h	24 h
Blood	63 ± 11^a	23 ± 2^d,e	2.1 ± 0.2^b	67 ± 12
Lung	30 ± 3^a	16 ± 2^d,e	2.7 ± 0.4^b	7 ± 1^c
Liver	33 ± 2^a	8 ± 2^d,e	0.7 ± 0.3^b	0.6 ± 0.2^c
Spleen	37 ± 3^a	24 ± 6^d,e	0.7 ± 0.2^b	0.6 ± 0.2^c
Stomach	36 ± 4^a	22 ± 6^d,e	4.4 ± 0.6^b	6 ± 3^c
Duodenum	31 ± 8	19 ± 6^d,e	2.4 ± 1.2^b	3 ± 2^c
Kidney	0.038 ± 0.008	0.04 ± 0.01^d	0.029 ± 0.005	0.03 ± 0.01
Muscle	102 ± 20^a	62 ± 6^d,e	7.9 ± 0.7^b	11 ± 1^c
Bone	47 ± 8^a	28 ± 3^d,e	3.0 ± 0.5^b	4 ± 1^c

Results are presented as %ID/g (the mean values and standard deviation for four mice).

^aSignificant difference (p < 0.05) between [¹¹¹In]In-DOTA-ZCAIX:2 and [^99mTc]Tc(CO)₃-HE₃-ZCAIX:2;

^bSignificant difference (p < 0.05) between [¹¹¹In]In-DOTA-ZCAIX:2 and [¹¹¹In]In-G250(Fab’)₂ (4 h);

^cSignificant difference (p < 0.05) between [¹¹¹In]In-DOTA-ZCAIX:2 and [¹¹¹In]In-G250(Fab’)₂ (24 h);

^dSignificant difference (p < 0.05) between [^99mTc]Tc(CO)₃-HE₃-ZCAIX:2 and [¹¹¹In]In-G250(Fab’)₂ (4 h);

^eSignificant difference (p < 0.05) between [^99mTc]Tc(CO)₃-HE₃-ZCAIX:2 and [¹¹¹In]In-G250(Fab’)₂ (4 h).